— Know what they know.
Not Investment Advice

TWST NASDAQ

Twist Bioscience Corporation
1W: +12.0% 1M: -11.0% 3M: +87.0% YTD: +393.5% 1Y: +368.6% 3Y: +854.3% 5Y: +33.4%
$159.85
+14.60 (+10.05%)
 
Weekly Expected Move ±14.1%
$100 $120 $140 $160 $179
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $10.5B mcap · 62M float · 3.42% daily turnover · Short 53% of daily vol
Credit Risk of going bust: lower than 76% of companies Debt: 0.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.04 (down more than 99.9%), Twist Bioscience Corporation would be worth roughly what it owes.
Total debt $93.6M against a stock market value of $10.52B.
Distance to default 8.83 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $8.6M (short-term plus half of long-term), stock volatility 77.6%; Altman Z'' -4.23. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -29.2%  ·  5Y Avg: -34.9%
Cost Advantage
59
Intangibles
44
Switching Cost
57
Network Effect
72
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TWST shows a Weak competitive edge (51.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -29.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$115
Low
$167
Avg Target
$215
High
Based on 9 analysts since Aug 3, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 2Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$167.33
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-12 Canaccord Genuity — $120 $205 +85 +28.3% $159.78
2026-10-08 Jefferies Matthew Stanton Initiated $150 — -3.6% $155.65
2026-10-07 Barclays — $95 $215 +120 +28.8% $166.97
2026-10-01 Guggenheim — $107 $212 +105 +7.5% $197.20
2026-09-29 Leerink Partners Puneet Souda $160 $190 +30 +4.3% $182.09
2026-09-17 Leerink Partners Puneet Souda $110 $160 +50 +11.8% $143.07
2026-09-09 UBS — $89 $144 +55 +12.4% $128.06
2026-08-05 Piper Sandler — $85 $115 +30 +15.6% $99.44
2026-08-04 Robert W. Baird — $65 $115 +50 +13.8% $101.06
2026-07-16 Leerink Partners Puneet Souda $80 $110 +30 +18.8% $92.61
2026-07-14 Canaccord Genuity Kyle Mikson $90 $120 +30 +32.8% $90.35
2026-07-06 Evercore ISI — $52 $102 +50 +4.1% $97.95
2026-06-29 Guggenheim — $60 $107 +47 +7.2% $99.84
2026-06-24 Barclays Luke Sergott $65 $95 +30 +11.8% $85.00
2026-06-15 Cowen & Co. — Initiated $89 — +16.8% $76.17
2026-06-15 Canaccord Genuity — Initiated $90 — +18.2% $76.17
2026-06-15 UBS — Initiated $89 — +16.8% $76.17
2026-06-11 Piper Sandler David Westenberg Initiated $85 — +25.4% $67.77
2026-05-22 Leerink Partners Puneet Souda Initiated $80 — +36.0% $58.84
2026-05-05 Guggenheim Subbu Nambi $50 $60 +10 +6.8% $56.19
2026-05-05 Robert W. Baird Catherine Ramsey Schulte $50 $65 +15 +15.7% $56.19
2026-05-04 Barclays — $55 $65 +10 +15.7% $56.19
2026-04-14 Barclays Luke Sergott $50 $55 +5 +9.2% $50.38
2026-02-03 Robert W. Baird — $44 $50 +6 +4.8% $47.73
2026-02-03 Evercore ISI — $42 $52 +10 +9.7% $47.42
2026-02-03 Barclays — $39 $50 +11 +6.8% $46.81
2026-01-05 Evercore ISI — $46 $42 -4 +22.3% $34.35
2025-12-15 Barclays — $40 $39 -1 +26.1% $30.94
2025-11-03 Stephens Steven Etoch Initiated $41 — +29.9% $31.57
2025-10-02 Barclays — $58 $40 -18 +36.7% $29.26
2025-08-04 Evercore ISI — $36 $46 +10 +52.3% $30.21
2025-05-06 Robert W. Baird Catherine Ramsey Schulte $54 $44 -10 +34.4% $32.75
2025-03-28 Guggenheim — $53 $50 -3 +23.9% $40.36
2025-02-04 Robert W. Baird Catherine Ramsey Schulte $46 $54 +8 +3.8% $52.02
2025-02-03 Barclays Luke Sergott $32 $58 +26 +10.0% $52.75
2024-09-17 Robert W. Baird Catherine Schulte $40 $46 +6 -4.5% $48.18
2024-06-05 Guggenheim Subbu Nambi Initiated $53 — +12.8% $46.98
2024-05-03 Robert W. Baird Catherine Ramsey Schulte Initiated $40 — +25.0% $32.01
2024-01-16 Goldman Sachs Matthew Sykes Initiated $45 — +29.2% $34.84
2023-02-05 Barclays Luke Sergott $45 $32 -13 +26.4% $25.31
2023-01-03 Evercore ISI — Initiated $36 — +45.6% $24.73
2022-10-06 Barclays Luke Sergott Initiated $45 — +16.9% $38.51

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
2
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TWST receives an overall rating of C-. Areas of concern: DCF (2/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C C-
2026-08-18 C- C
2026-08-14 C C-
2026-07-30 C- C
2026-04-01 C C-
2026-02-02 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 36 Grade D
Profitability
16
Balance Sheet
86
Earnings Quality
42
Growth
48
Value
27
Momentum
47
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TWST scores highest in Safety (100/100) and lowest in Profitability (16/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
14.36
Safe Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-2.76
Unlikely Manipulator
Ohlson O-Score
-6.64
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
A
Score: 74.4/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.39x
Accruals: -12.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TWST scores 14.36, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TWST scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TWST's score of -2.76 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TWST's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TWST receives an estimated rating of A (score: 74.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-72.00x
PEG
1.10x
P/S
24.37x
P/B
22.38x
P/FCF
-68.94x
P/OCF
—
EV/EBITDA
-58.88x
EV/Revenue
14.70x
EV/EBIT
-47.66x
EV/FCF
-68.15x
Earnings Yield
-2.13%
FCF Yield
-1.45%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TWST currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.006
NI / EBT
×
Interest Burden
1.020
EBT / EBIT
×
EBIT Margin
-0.308
EBIT / Rev
×
Asset Turnover
0.656
Rev / Assets
×
Equity Multiplier
1.424
Assets / Equity
=
ROE
-29.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TWST's ROE of -29.6% is driven by Asset Turnover (0.656), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$159.85
Median 1Y
$149.80
5th Pctile
$43.25
95th Pctile
$516.24
Ann. Volatility
78.4%
Analyst Target
$167.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Emily M. Leproust,
Ph.D. Chief Executive Officer and Chair of the Board
$720,000 $11,998,134 $13,781,570
Patrick Finn, Ph.D.
President and Chief Operating Officer
$563,000 $6,748,947 $8,022,942
Adam Laponis Financial
ancial Officer
$490,000 $3,365,430 $4,216,117
Dennis Cho Legal
Legal Officer and Corporate Secretary
$449,000 $2,872,062 $3,621,076
Paula Green Human
r Vice President of Human Resources
$400,000 $2,570,537 $3,348,859

CEO Pay Ratio

55:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $13,781,570
Avg Employee Cost (SGA/emp): $252,274
Employees: 979

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
979
+6.1% YoY
Revenue / Employee
$384,650
Rev: $376,572,000
Profit / Employee
$-79,336
NI: $-77,670,000
SGA / Employee
$252,274
Avg labor cost proxy
R&D / Employee
$82,007
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE -33.2% -26.1% -25.4% -29.1% -31.8% -31.2% -27.1% -28.3% -29.0% -30.8% -30.4% -38.4% -38.1% -37.7% -38.2% -17.6% -16.4% -16.8% -18.2% -29.6% -29.59%
ROA -27.6% -22.2% -22.1% -24.4% -26.2% -25.2% -22.7% -23.4% -23.5% -25.1% -24.7% -30.4% -30.0% -29.4% -29.4% -13.3% -12.4% -12.3% -12.8% -20.8% -20.78%
ROIC -72.7% -35.0% -42.5% -46.3% -48.9% -44.0% -43.5% -45.0% -45.0% -46.8% -45.9% -64.2% -62.0% -61.5% -60.4% -36.8% -28.5% -24.0% -27.4% -29.2% -29.22%
ROCE -24.0% -25.0% -21.3% -24.6% -26.2% -25.9% -27.1% -28.2% -28.9% -30.6% -30.1% -39.0% -38.3% -36.5% -36.6% -15.2% -13.9% -14.0% -14.0% -24.1% -24.12%
Gross Margin 40.7% 35.6% 38.3% 44.8% 44.9% 45.7% 30.8% 34.4% 36.6% 40.5% 41.0% 43.3% 45.1% 48.3% 49.6% 53.4% 51.3% 52.0% 51.6% 52.8% 52.76%
Operating Margin -1.0% -1.3% -1.3% -1.1% -99.2% -82.3% -1.0% -95.4% -74.9% -65.7% -64.9% -1.1% -42.5% -39.1% -44.8% -31.4% -30.2% -31.7% -34.9% -30.6% -30.65%
Net Margin -1.1% -1.1% -1.3% -1.1% -89.2% -77.1% -98.3% -90.0% -69.1% -60.2% -60.4% -1.1% -40.9% -35.6% -42.4% 21.2% -27.4% -29.4% -39.8% -29.6% -29.61%
EBITDA Margin -1.0% -1.3% -1.2% -1.0% -80.0% -67.2% -85.5% -75.7% -56.7% -48.6% -48.9% -94.6% -33.1% -28.3% -35.1% 27.5% -21.1% -25.8% -29.1% -23.6% -23.62%
FCF Margin -1.1% -1.2% -1.3% -1.4% -1.1% -1.1% -92.9% -70.0% -69.5% -49.1% -34.4% -25.4% -22.1% -20.7% -18.8% -19.0% -20.1% -22.1% -23.2% -21.6% -21.57%
OCF Margin -84.8% -91.6% -93.0% -85.7% -61.1% -61.1% -58.7% -52.3% -58.1% -42.5% -31.2% -23.5% -20.5% -18.9% -16.1% -14.1% -12.6% -13.0% -13.6% -12.3% -12.29%
ROE 3Y Avg snapshot only -31.11%
ROE 5Y Avg snapshot only -30.11%
ROA 3Y Avg snapshot only -22.70%
ROIC 3Y Avg snapshot only -30.45%
ROIC Economic snapshot only -20.51%
Cash ROA snapshot only -7.89%
Cash ROIC snapshot only -14.25%
CROIC snapshot only -25.00%
NOPAT Margin snapshot only -25.21%
Pretax Margin snapshot only -31.46%
R&D / Revenue snapshot only 16.64%
SGA / Revenue snapshot only 67.23%
SBC / Revenue snapshot only 15.39%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio -34.71 -23.44 -14.08 -9.46 -9.10 -6.28 -4.03 -5.57 -5.67 -10.30 -10.32 -13.01 -12.56 -13.93 -12.25 -26.42 -21.89 -25.30 -36.08 -46.96 -72.005
P/S Ratio 39.89 26.42 16.19 10.68 9.74 6.23 3.76 4.96 4.73 8.08 7.14 9.71 8.38 8.33 6.74 6.21 4.52 4.95 7.16 14.87 24.371
P/B Ratio 9.09 6.17 3.06 2.40 2.51 1.80 1.22 1.77 1.86 3.59 3.54 5.83 5.55 6.03 5.32 4.71 3.60 4.25 6.44 14.40 22.379
P/FCF -37.90 -22.70 -12.48 -7.83 -8.76 -5.78 -4.04 -7.08 -6.82 -16.45 -20.75 -38.23 -37.89 -40.20 -35.76 -32.75 -22.48 -22.34 -30.82 -68.94 -68.941
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -33.79 -21.88 -11.44 -7.44 -7.43 -5.12 -2.95 -4.96 -5.27 -11.02 -11.27 -14.27 -13.75 -15.33 -13.29 -34.98 -30.75 -35.74 -53.44 -58.88 -58.881
EV/Revenue 36.76 24.86 13.16 8.24 7.73 4.63 2.46 3.83 3.75 7.24 6.41 9.02 7.76 7.76 6.23 5.73 4.26 4.91 6.98 14.70 14.698
EV/EBIT -31.65 -20.55 -10.74 -6.96 -6.89 -4.67 -2.64 -4.35 -4.51 -9.29 -9.30 -12.11 -11.67 -13.02 -11.36 -24.55 -20.91 -24.59 -36.68 -47.66 -47.656
EV/FCF -34.92 -21.35 -10.15 -6.04 -6.95 -4.29 -2.64 -5.48 -5.39 -14.75 -18.62 -35.53 -35.13 -37.45 -33.06 -30.24 -21.22 -22.18 -30.02 -68.15 -68.155
Earnings Yield -2.9% -4.3% -7.1% -10.6% -11.0% -15.9% -24.8% -18.0% -17.6% -9.7% -9.7% -7.7% -8.0% -7.2% -8.2% -3.8% -4.6% -4.0% -2.8% -2.1% -2.13%
FCF Yield -2.6% -4.4% -8.0% -12.8% -11.4% -17.3% -24.7% -14.1% -14.7% -6.1% -4.8% -2.6% -2.6% -2.5% -2.8% -3.1% -4.4% -4.5% -3.2% -1.5% -1.45%
PEG Ratio snapshot only 1.099
Price/Tangible Book snapshot only 18.300
EV/Gross Profit snapshot only 28.285
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 8.67 4.81 7.85 6.73 6.58 6.46 6.79 6.12 5.79 5.98 5.51 4.91 4.88 4.96 4.51 3.90 3.64 3.78 2.70 2.67 2.672
Quick Ratio 8.16 4.31 7.32 6.27 6.15 5.93 6.23 5.62 5.35 5.51 5.06 4.52 4.54 4.62 4.24 3.60 3.33 3.37 2.42 2.38 2.379
Debt/Equity 0.11 0.12 0.09 0.10 0.12 0.13 0.13 0.14 0.15 0.16 0.16 0.18 0.18 0.18 0.18 0.16 0.29 0.40 0.21 0.21 0.210
Net Debt/Equity -0.71 -0.37 -0.57 -0.55 -0.52 -0.46 -0.42 -0.40 -0.39 -0.37 -0.36 -0.41 -0.40 -0.41 -0.40 -0.36 -0.20 -0.03 -0.17 -0.16 -0.164
Debt/Assets 0.09 0.09 0.08 0.08 0.10 0.10 0.11 0.11 0.12 0.13 0.13 0.14 0.14 0.14 0.13 0.12 0.21 0.29 0.14 0.14 0.139
Debt/EBITDA -0.44 -0.44 -0.42 -0.38 -0.45 -0.48 -0.48 -0.51 -0.54 -0.53 -0.57 -0.47 -0.48 -0.49 -0.49 -1.32 -2.63 -3.42 -1.79 -0.87 -0.868
Net Debt/EBITDA 2.88 1.38 2.63 2.20 1.94 1.76 1.56 1.45 1.39 1.27 1.29 1.08 1.08 1.13 1.09 2.91 1.82 0.26 1.42 0.68 0.680
Interest Coverage -419.84 -645.50 -961.02 -1581.26 -2817.20 -3821.39 -7299.59 -6926.47 -40692.20 -51150.50 -95635.50 -219879.00 -7177.17 -3711.75 -972.38 -431.76 -459.78 -546.93 — — —
Equity Multiplier 1.21 1.26 1.18 1.19 1.22 1.22 1.21 1.23 1.25 1.24 1.25 1.30 1.30 1.33 1.35 1.35 1.36 1.40 1.49 1.51 1.509
Cash Ratio snapshot only 1.387
Cash to Debt snapshot only 1.783
FCF to Debt snapshot only -0.995
Defensive Interval snapshot only 234.4 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.24 0.20 0.19 0.22 0.24 0.25 0.24 0.26 0.28 0.32 0.36 0.41 0.45 0.49 0.54 0.57 0.60 0.63 0.64 0.66 0.656
Inventory Turnover 3.66 3.34 3.32 3.43 3.36 2.87 3.16 3.64 4.35 4.47 4.87 5.42 6.40 6.73 7.23 6.76 7.08 6.71 7.22 6.79 6.789
Receivables Turnover 5.13 5.82 6.17 6.19 6.14 6.52 6.37 6.41 5.83 7.04 7.04 8.56 7.93 8.84 8.09 8.85 8.19 8.76 7.18 7.52 7.515
Payables Turnover 8.17 5.59 7.91 6.83 6.82 5.64 8.90 8.71 9.10 11.47 16.35 18.67 22.91 21.83 23.51 19.76 29.17 18.95 17.26 14.29 14.291
DSO 71 63 59 59 59 56 57 57 63 52 52 43 46 41 45 41 45 42 51 49 48.6 days
DIO 100 109 110 106 109 127 115 100 84 82 75 67 57 54 50 54 52 54 51 54 53.8 days
DPO 45 65 46 53 54 65 41 42 40 32 22 20 16 17 16 18 13 19 21 26 25.5 days
Cash Conversion Cycle 126 107 123 112 115 118 132 115 106 102 104 90 87 79 80 77 84 77 80 77 76.8 days
Fixed Asset Turnover snapshot only 2.391
Operating Cycle snapshot only 102.3 days
Cash Velocity snapshot only 2.588
Capital Intensity snapshot only 1.557
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 46.9% 44.6% 44.3% 45.3% 53.8% 47.6% 39.7% 27.8% 20.4% 21.6% 21.8% 25.4% 27.7% 25.9% 25.3% 22.7% 20.3% 18.6% 17.8% 19.2% 19.19%
Net Income -8.7% -40.6% -52.0% -53.9% -43.2% -30.0% -13.4% -0.7% 6.1% 3.9% 9.6% -5.2% -2.0% 4.1% 0.5% 61.3% 62.8% 61.2% 57.5% -60.5% -60.49%
EPS 1.4% -29.6% -38.5% -33.8% -25.6% -14.9% -6.8% 0.6% 7.7% 5.6% 11.2% -3.2% -0.7% 6.8% 3.6% 63.2% 64.3% 62.4% 58.9% -57.3% -57.30%
FCF 8.4% -18.4% -83.5% -1.0% -62.4% -36.7% -0.1% 34.4% 24.7% 44.6% 54.9% 54.5% 59.4% 46.9% 31.4% 8.3% -9.3% -26.8% -45.3% -35.5% -35.52%
EBITDA -9.0% -52.5% -64.2% -60.0% -47.0% -17.6% -1.3% 10.9% 17.7% 11.7% 16.9% -2.5% -1.5% 3.1% -3.2% 68.2% 70.5% 67.8% 67.2% -81.5% -81.51%
Op. Income -9.0% -50.3% -61.6% -59.1% -53.7% -27.1% -12.9% -2.8% 7.5% 1.8% 7.8% -4.9% -1.7% 5.0% 2.7% 39.4% 38.3% 35.5% 34.6% 3.2% 3.23%
OCF Growth snapshot only -3.79%
Asset Growth snapshot only 4.48%
Equity Growth snapshot only -6.79%
Debt Growth snapshot only 19.76%
Shares Change snapshot only 2.03%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y — 1.3% 86.7% 68.3% 55.3% 53.2% 51.3% 47.5% 39.6% 37.4% 34.9% 32.5% 33.2% 31.2% 28.7% 25.3% 22.8% 22.0% 21.6% 22.4% 22.40%
Revenue 5Y — — — — — — — — — 86.9% 61.8% 50.2% 41.9% 40.6% 39.5% 37.6% 33.1% 31.1% 29.4% 27.8% 27.77%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — 2.6% 1.7% 1.3% 1.1% 85.9% 74.2% 46.2% 38.5% 36.5% 32.8% 37.1% 37.5% 37.2% 34.1% 31.4% 29.0% 31.3% 35.1% 35.13%
Gross Profit 5Y — — — — — — — — — — 1.4% 1.0% 80.5% 68.9% 61.8% 59.7% 46.1% 41.7% 38.6% 34.4% 34.43%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — 68.5% 93.9% 67.9% 72.6% 67.9% 38.1% 25.7% 24.9% 1.6% 1.2% -4.2% -4.4% -8.2% -16.5% -13.1% -12.6% -11.2% -7.5% -6.0% -6.03%
Assets 5Y — — — — — — — — — 34.8% 38.1% 25.3% 26.9% 25.9% 13.0% 9.5% 10.0% -1.8% -0.0% -1.5% -1.50%
Equity 3Y — 65.3% 95.5% 67.1% 73.1% 93.5% 38.6% 23.5% 22.8% -2.6% -3.0% -7.0% -6.6% -10.0% -20.1% -16.5% -15.7% -15.1% -13.5% -12.2% -12.15%
Book Value 3Y — 35.1% 57.4% 35.9% 44.3% 61.7% 20.4% 11.4% 13.2% -9.6% -8.4% -12.2% -11.5% -15.0% -23.0% -18.8% -17.7% -17.3% -15.9% -14.7% -14.75%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 1.00 1.00 1.00 0.99 0.97 0.98 0.99 1.00 0.99 0.99 0.99 1.00 0.99 0.99 1.00 1.00 1.00 1.00 1.00 1.00 0.996
Earnings Stability 0.94 0.70 0.76 0.84 0.91 0.83 0.84 0.86 0.88 0.81 0.76 0.86 0.83 0.67 0.53 0.00 0.02 0.01 0.05 0.12 0.117
Margin Stability 0.51 0.13 0.41 0.47 0.59 0.67 0.75 0.77 0.89 0.37 0.54 0.59 0.64 0.70 0.76 0.76 0.83 0.84 0.85 0.86 0.863
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.97 0.84 0.50 0.50 0.83 0.88 0.95 1.00 0.98 0.98 0.96 0.98 0.99 0.98 1.00 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.30 0.51 0.16 0.07 0.06 -0.06 -0.09 -0.08 -0.06 -0.07 -0.08 -0.16 -0.14 -0.11 -0.11 0.21 0.22 0.22 0.21 0.01 0.007
Gross Margin Trend 0.17 0.12 0.09 0.08 0.06 0.07 0.04 -0.02 -0.04 -0.05 -0.02 0.01 0.04 0.05 0.07 0.10 0.11 0.11 0.10 0.07 0.071
FCF Margin Trend 0.74 0.51 0.37 0.16 0.26 0.21 0.23 0.47 0.39 0.63 0.77 0.78 0.68 0.58 0.45 0.29 0.26 0.13 0.03 0.01 0.006
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 0.74 0.81 0.81 0.76 0.57 0.62 0.63 0.59 0.70 0.54 0.45 0.32 0.31 0.32 0.29 0.60 0.61 0.67 0.68 0.39 0.388
FCF/OCF 1.24 1.27 1.39 1.59 1.82 1.77 1.58 1.34 1.19 1.16 1.10 1.08 1.08 1.09 1.17 1.34 1.59 1.70 1.71 1.75 1.755
FCF/Net Income snapshot only 0.681
CapEx/Revenue 20.4% 24.8% 36.7% 50.7% 50.0% 46.8% 34.2% 17.8% 11.3% 6.7% 3.2% 1.9% 1.6% 1.8% 2.7% 4.9% 7.4% 9.1% 9.7% 9.3% 9.28%
CapEx/Depreciation snapshot only 1.577
Accruals Ratio -0.07 -0.04 -0.04 -0.06 -0.11 -0.10 -0.08 -0.10 -0.07 -0.11 -0.14 -0.21 -0.21 -0.20 -0.21 -0.05 -0.05 -0.04 -0.04 -0.13 -0.127
Sloan Accruals snapshot only -0.117
Cash Flow Adequacy snapshot only -1.325
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.2% 0.3% 0.3% 0.4% 0.4% 0.5% 0.7% 0.4% 0.4% 0.3% 0.3% 0.2% 0.2% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -5.9% 0.3% -9.9% -13.3% -13.2% -19.6% 0.7% 0.4% 0.4% 0.3% 0.3% 0.2% 0.2% 0.1% 0.0% -0.1% -0.1% -0.1% -0.2% -0.1% -0.13%
Total Shareholder Return -5.9% 0.3% -9.9% -13.3% -13.2% -19.6% 0.7% 0.4% 0.4% 0.3% 0.3% 0.2% 0.2% 0.1% 0.0% -0.1% -0.1% -0.1% -0.2% -0.1% -0.13%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.99 0.93 0.94 0.95 0.95 1.00 1.00 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.006
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.97 1.03 1.02 1.020
EBIT Margin -1.16 -1.21 -1.23 -1.18 -1.12 -0.99 -0.93 -0.88 -0.83 -0.78 -0.69 -0.74 -0.67 -0.60 -0.55 -0.23 -0.20 -0.20 -0.19 -0.31 -0.308
Asset Turnover 0.24 0.20 0.19 0.22 0.24 0.25 0.24 0.26 0.28 0.32 0.36 0.41 0.45 0.49 0.54 0.57 0.60 0.63 0.64 0.66 0.656
Equity Multiplier 1.20 1.18 1.15 1.19 1.21 1.24 1.20 1.21 1.23 1.23 1.23 1.26 1.27 1.28 1.30 1.32 1.33 1.37 1.42 1.42 1.424
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $-3.08 $-3.30 $-3.51 $-3.70 $-3.87 $-3.79 $-3.74 $-3.67 $-3.57 $-3.58 $-3.33 $-3.79 $-3.60 $-3.34 $-3.20 $-1.39 $-1.29 $-1.25 $-1.32 $-2.19 $-2.19
Book Value/Share $11.77 $12.55 $16.15 $14.58 $14.03 $13.22 $12.40 $11.53 $10.88 $10.26 $9.69 $8.45 $8.15 $7.71 $7.38 $7.82 $7.83 $7.47 $7.38 $7.14 $7.14
Tangible Book/Share $10.94 $9.58 $13.38 $11.97 $11.44 $10.67 $9.88 $9.05 $8.43 $7.84 $7.31 $6.72 $6.42 $6.02 $5.71 $6.25 $6.24 $5.91 $5.83 $5.62 $5.62
Revenue/Share $2.68 $2.93 $3.05 $3.27 $3.62 $3.82 $4.01 $4.13 $4.28 $4.56 $4.80 $5.08 $5.39 $5.58 $5.83 $5.92 $6.23 $6.41 $6.64 $6.92 $6.92
FCF/Share $-2.82 $-3.41 $-3.96 $-4.47 $-4.02 $-4.12 $-3.73 $-2.89 $-2.97 $-2.24 $-1.65 $-1.29 $-1.19 $-1.16 $-1.10 $-1.12 $-1.25 $-1.42 $-1.54 $-1.49 $-1.49
OCF/Share $-2.27 $-2.68 $-2.84 $-2.81 $-2.21 $-2.34 $-2.36 $-2.16 $-2.49 $-1.94 $-1.50 $-1.19 $-1.10 $-1.06 $-0.94 $-0.84 $-0.79 $-0.84 $-0.90 $-0.85 $-0.85
Cash/Share $9.68 $6.05 $10.73 $9.37 $8.97 $7.77 $6.83 $6.26 $5.87 $5.41 $5.08 $4.98 $4.76 $4.58 $4.31 $4.10 $3.85 $3.24 $2.78 $2.67 $2.67
EBITDA/Share $-2.92 $-3.33 $-3.51 $-3.63 $-3.76 $-3.46 $-3.35 $-3.19 $-3.04 $-3.00 $-2.73 $-3.21 $-3.05 $-2.82 $-2.73 $-0.97 $-0.86 $-0.88 $-0.87 $-1.73 $-1.73
Debt/Share $1.27 $1.46 $1.49 $1.40 $1.69 $1.66 $1.61 $1.63 $1.64 $1.60 $1.55 $1.50 $1.47 $1.40 $1.35 $1.28 $2.27 $3.01 $1.55 $1.50 $1.50
Net Debt/Share $-8.41 $-4.59 $-9.24 $-7.98 $-7.29 $-6.11 $-5.22 $-4.63 $-4.23 $-3.81 $-3.53 $-3.48 $-3.30 $-3.18 $-2.96 $-2.82 $-1.57 $-0.23 $-1.23 $-1.17 $-1.17
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 14.364
Altman Z-Prime snapshot only 23.437
Piotroski F-Score 4 3 2 4 3 4 2 2 2 2 4 3 3 3 3 5 4 4 4 2 2
Beneish M-Score -0.50 14.02 5.43 -1.68 -2.00 -2.82 -2.52 -2.72 -2.59 -3.06 -3.40 -3.93 -3.89 -3.60 -3.44 -2.22 -2.07 -2.30 -2.23 -2.76 -2.758
Ohlson O-Score snapshot only -6.643
ROIC (Greenblatt) snapshot only -34.89%
Net-Net WC snapshot only $1.52
EVA snapshot only $-146089670.00
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only A
Credit Score 59.35 60.99 61.93 63.91 64.09 61.95 49.69 54.28 54.58 65.69 65.06 65.43 65.07 65.32 65.56 65.09 60.41 62.99 74.57 74.43 74.425
Credit Grade snapshot only 6
Credit Trend snapshot only 9.331
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 69

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms